Comparative Efficacy and Safety of Semaglutide, Cagrilintide, and CagriSema in Adults with Overweight or Obesity: A Bayesian Network Meta Analysis Journal of Clinical Question Cagrilintide: The Next Gen Peptide for Weight Loss and Satiety Hubmed When do we choose semaglotide and when does terzipatide? EASO has just announced that it will update its algorithm with evidence until November 2025 Warning: It depends on the clinical goal. Novo Nordisk launches trial of pipeline drug CagriSema versus newly approved Zepbound Clinical Trials Arena Zepbound beats CagriSema in head to head trial : r Zepbound